This article discusses the challenges of recurrence in early-stage non-small-cell adenocarcinoma, a type of lung cancer. The study highlights the importance of nomograms, which are personalized prognostic evaluations that incorporate various factors, in predicting outcomes for patients. Additionally, the article emphasizes the significance of coagulation abnormalities as indicators of poor outcomes and the potential for thrombus formation and metastasis. The study concludes that a multifaceted approach, including the use of nomograms and recognizing coagulation abnormalities, can help identify high-risk patients and improve outcomes by mitigating recurrence risks. However, the study acknowledges limitations such as its retrospective nature and the need for longer follow-up periods and more robust biomarkers. [Extracted from the article]